These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 16579750)
1. In vitro evaluation of the effect of a novel immunosuppressive agent, FTY720, on the function of feline neutrophils. Chen YJ; Kyles AE; Gregory CR Am J Vet Res; 2006 Apr; 67(4):588-92. PubMed ID: 16579750 [TBL] [Abstract][Full Text] [Related]
2. The immunomodulator FTY720 is phosphorylated and released from platelets. Anada Y; Igarashi Y; Kihara A Eur J Pharmacol; 2007 Jul; 568(1-3):106-11. PubMed ID: 17553484 [TBL] [Abstract][Full Text] [Related]
3. Oral pharmacokinetic and pharmacodynamic effects of FTY720 in cats. Downes S; Chen YJ; Kyles A; Gregory C J Vet Pharmacol Ther; 2007 Feb; 30(1):55-61. PubMed ID: 17217402 [TBL] [Abstract][Full Text] [Related]
4. FTY720 therapy exerts differential effects on T cell subsets in multiple sclerosis. Mehling M; Brinkmann V; Antel J; Bar-Or A; Goebels N; Vedrine C; Kristofic C; Kuhle J; Lindberg RL; Kappos L Neurology; 2008 Oct; 71(16):1261-7. PubMed ID: 18852441 [TBL] [Abstract][Full Text] [Related]
5. FTY720 preferentially depletes naive T cells from peripheral and lymphoid organs. Hofmann M; Brinkmann V; Zerwes HG Int Immunopharmacol; 2006 Dec; 6(13-14):1902-10. PubMed ID: 17161343 [TBL] [Abstract][Full Text] [Related]
6. The sphingosine 1-phosphate receptor agonist FTY720 potently inhibits regulatory T cell proliferation in vitro and in vivo. Wolf AM; Eller K; Zeiser R; Dürr C; Gerlach UV; Sixt M; Markut L; Gastl G; Rosenkranz AR; Wolf D J Immunol; 2009 Sep; 183(6):3751-60. PubMed ID: 19692647 [TBL] [Abstract][Full Text] [Related]
7. FTY720 improves survival after transient ischemia and reperfusion of the hind limbs. Frink M; Kaudel CP; Hildebrand F; Pape HC; Klempnauer J; Winkler M; Krettek C; van Griensven M J Trauma; 2007 Aug; 63(2):263-7. PubMed ID: 17693822 [TBL] [Abstract][Full Text] [Related]
9. FTY720, a synthetic compound from Isaria sinclairii, inhibits proliferation and induces apoptosis in pancreatic cancer cells. Shen Y; Cai M; Xia W; Liu J; Zhang Q; Xie H; Wang C; Wang X; Zheng S Cancer Lett; 2007 Sep; 254(2):288-97. PubMed ID: 17462818 [TBL] [Abstract][Full Text] [Related]
10. FTY720 ameliorates oxazolone colitis in mice by directly affecting T helper type 2 functions. Daniel C; Sartory NA; Zahn N; Schmidt R; Geisslinger G; Radeke HH; Stein JM Mol Immunol; 2007 Jul; 44(13):3305-16. PubMed ID: 17475330 [TBL] [Abstract][Full Text] [Related]
11. Sphingosine 1-phosphate receptor agonism impairs skin dendritic cell migration and homing to secondary lymphoid tissue: association with prolonged allograft survival. Lan YY; Tokita D; Wang Z; Wang HC; Zhan J; Brinkmann V; Thomson AW Transpl Immunol; 2008 Nov; 20(1-2):88-94. PubMed ID: 18694829 [TBL] [Abstract][Full Text] [Related]
12. FTY720 induced Bcl-associated and Fas-independent apoptosis in human renal cancer cells in vitro and significantly reduced in vivo tumor growth in mouse xenograft. Ubai T; Azuma H; Kotake Y; Inamoto T; Takahara K; Ito Y; Kiyama S; Sakamoto T; Horie S; Muto S; Takahara S; Otsuki Y; Katsuoka Y Anticancer Res; 2007; 27(1A):75-88. PubMed ID: 17352219 [TBL] [Abstract][Full Text] [Related]
14. Evidence that FTY720 induces rat thymocyte apoptosis. Isoyama N; Takai K; Tsuchida M; Matsumura M; Naito K Transpl Immunol; 2006 Apr; 15(4):265-71. PubMed ID: 16635748 [TBL] [Abstract][Full Text] [Related]
15. Prolonged administration of FTY720 does not cause renal toxicity in mice. Galvão VR; Ginoza M; Franco M; Burdmann EA; Bueno V Transplant Proc; 2005; 37(1):112-3. PubMed ID: 15808564 [TBL] [Abstract][Full Text] [Related]
16. The immunomodulator FTY720 has a direct cytoprotective effect in oligodendrocyte progenitors. Coelho RP; Payne SG; Bittman R; Spiegel S; Sato-Bigbee C J Pharmacol Exp Ther; 2007 Nov; 323(2):626-35. PubMed ID: 17726159 [TBL] [Abstract][Full Text] [Related]
17. FTY720: placebo-controlled study of the effect on cardiac rate and rhythm in healthy subjects. Schmouder R; Serra D; Wang Y; Kovarik JM; DiMarco J; Hunt TL; Bastien MC J Clin Pharmacol; 2006 Aug; 46(8):895-904. PubMed ID: 16855074 [TBL] [Abstract][Full Text] [Related]
18. FTY720 induces apoptosis in hepatocellular carcinoma cells through activation of protein kinase C delta signaling. Hung JH; Lu YS; Wang YC; Ma YH; Wang DS; Kulp SK; Muthusamy N; Byrd JC; Cheng AL; Chen CS Cancer Res; 2008 Feb; 68(4):1204-12. PubMed ID: 18281497 [TBL] [Abstract][Full Text] [Related]
19. FTY720 modulates human oligodendrocyte progenitor process extension and survival. Miron VE; Jung CG; Kim HJ; Kennedy TE; Soliven B; Antel JP Ann Neurol; 2008 Jan; 63(1):61-71. PubMed ID: 17918267 [TBL] [Abstract][Full Text] [Related]
20. Differential effects of single dose FTY720 on CD62L+ B-cells in stable renal allograft recipients. Böhler T; Schütz M; Budde K; Neumayer HH; Waiser J Int Immunopharmacol; 2007 Jan; 7(1):88-95. PubMed ID: 17161821 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]